Monday, April 6

Concerns over rising medical costs and lack of transparency in private healthcare have come under sharp focus after an Assam-based doctor publicly criticised alleged overbilling practices in corporate hospitals. The issue has triggered widespread debate among medical professionals and the public alike.


Doctor Raises Alarm Over “Financial Sinkhole” in Private Healthcare

Dr. Priyam Bordoloi, an Internal Medicine specialist from Guwahati, has accused certain corporate hospital chains of engaging in what he termed “predatory” billing practices. He warned that such systems are increasingly becoming a “financial sinkhole” for patients and their families.

His remarks came in response to a social media post highlighting exorbitant ICU treatment costs, where daily medicine expenses alone reportedly ranged between ₹40,000 and ₹50,000—excluding hospital stay and other charges.


ICU Transparency Under Question

The viral post described a case where a patient’s family was denied access to the ICU and not provided with clear details about ongoing treatment. The lack of transparency raised serious concerns:

  • Families unable to verify medicines administered
  • No clarity on diagnostic tests conducted
  • Limited or no communication from hospital authorities

The post alleged that patients’ relatives are often left with no option but to keep paying, especially in critical care situations.


Doctor Shares Personal Experience of High Billing

Backing the concerns, Dr. Bordoloi shared his own experience of recommending a private hospital for a relative suffering from a minor illness. The patient was discharged after three days with a bill of ₹64,000.

He pointed out issues such as:

  • Inflated pricing of medicines
  • Unnecessary diagnostic tests (including vitamin panels)
  • CT scans conducted without strong clinical indication
  • Overuse of antibiotics

According to him, while better infrastructure and staffing may justify some costs, the absence of transparency makes the system exploitative.


“MBA-Driven Medicine” Criticised by Medical Community

The controversy has sparked reactions from other healthcare professionals, with some blaming the corporatisation of healthcare.

One doctor remarked that “MBA-driven medicine” is becoming a major issue, where revenue targets influence clinical decisions. Another medical professional added that while doctors are part of the system, the root cause lies in corporate-driven profit models rather than individual practitioners.


Case at Apollo Hospital Vashi Raises Billing Concerns

Adding to the debate, a user shared an incident involving a colleague treated at Apollo Hospital Vashi for emergency angioplasty.

  • Initial estimate: ₹5.87 lakh
  • Final bill: ₹8.78 lakh

The user alleged that despite staying in a shared ICU initially, the patient was later charged for a “Special ICU” retrospectively—raising questions about billing practices and accountability.


Growing Demand for Regulation and Transparency

The issue has reignited calls for stricter regulation of private hospitals, standardized pricing, and improved patient communication.

As healthcare costs continue to rise, experts stress the need for:

  • Transparent billing systems
  • Clear treatment communication
  • Ethical clinical practices

The ongoing debate highlights a critical challenge in India’s healthcare system—balancing quality care with affordability and trust.

Share.
Leave A Reply

Doctors Post is a news portal tailored to provide current news & updates on issues related exclusively to medical & healthcare professionals. The content of Doctor Post is judiciously authored by a dedicated team of legal experts, doctors and reporters.  The intent of the content is to expeditiously update doctor’s information & news necessary for the smooth functioning of their profession.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version